Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (15859)	11/23/2002 12:58:35 PM
From: Joan Osland Graffius	Respond to of 78523

Spekulatius, I have also been looking at STO. I agree with the 3 points you make on the risk. I believe STO represents 17% of the Norwegian oil resources and the rest is owned by the government. Do you have any information on the companies pension plan and their dividend policy? On the positive side, the Norwegian government ledger has a positive balance sheet if you look at the debt vs. assets. Their currency does fluctuate with the price of oil but I can not see the currency having problems with the competing currencies in today’s environment where most governments are deep in debt and a large portion of taxes are spent on servicing the debt. I am looking for an entry point in this stock for a first third position. Joan

To: Spekulatius who wrote (15859)	12/3/2002 8:58:15 PM
From: Paul Senior	Read Replies (1) \| Respond to of 78523

OT: Speculatius, fwiw, I started a very small position in OFIX. I'd call it a GAARP play. The company has generally had good growth and profits due to the success of a key product. They are a small company trying to expand their product line(s). The stock's a little expensive at over twice book and twice sales. Margins are good now though, and debt is low. I don't know what a decent p/e multiple ought to be for this company. I mention the stock here because several people might be familiar with ZMH, the BMY spin off. ZMH, as you probably know, is one of the dominant businesses (along with JNJ, if I recall) in orthopedics. ZMH sells for almost twice the multiple that OFIX does. And given its size and scope, maybe it should. In any case, I sold my ZMH holdings several months ago, and now OFIX has some appeal to me. Paul Senior